Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shu Zhen-lin"'
Autor:
Gong Fu-han, Xiao Xiao-qiang, Zhang Xue-ping, Long Li, Huang Sheng, Wang Xue-sheng, Shu Zhen-lin, Yang Yong-sheng
Publikováno v:
Open Medicine, Vol 14, Iss 1, Pp 939-944 (2019)
Atherosclerosis and chemokines are strongly related, but the role of the chemokine CXCL17 in atherogenesis is still poorly understood. We aim to investigate the serum CXCL17 levels in different stages of patients with coronary heart disease and explo
Externí odkaz:
https://doaj.org/article/8c264777d795436cbec3225759ff69b4
Autor:
Man chung Chan, Xin-yi Xu, Yanyan Zhuang, Wa Zhong, Ke Jiang, Shu-zhen Lin, Zhong-sheng Xia, Wen-fei Li
Publikováno v:
Cell Death Discovery
Cell Death Discovery, Vol 7, Iss 1, Pp 1-12 (2021)
Cell Death Discovery, Vol 7, Iss 1, Pp 1-12 (2021)
Colorectal cancer (CRC) is the most common form of gastrointestinal malignancies. A growing number of reports focusing on oxaliplatin (OXA) resistance in CRC treatment have revealed that drug resistance is an urgent issue in clinical applications, es
Publikováno v:
Zhongguo Dang Dai Er Ke Za Zhi
OBJECTIVE: To systematically review the prevalence of pediatric asthma in the rural areas of China, and to provide data for the prevention and treatment of pediatric asthma. METHODS: PubMed, Cochrane, China National Knowledge Infrastructure, Wanfang
Publikováno v:
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology. 23(4)
To evaluate the relationship between the levels of HBV DNA loads and both the clinical characteristics and 48-week prognosis in patients with decompensated cirrhosis due to hepatitis B.One hundred and forty-three patients with decompensated cirrhosis
Autor:
Yan-yan Zhuang, Wa Zhong, Zhong-sheng Xia, Shu-zhen Lin, Man chung Chan, Ke Jiang, Wen-fei Li, Xin-yi Xu
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-12 (2021)
Abstract Colorectal cancer (CRC) is the most common form of gastrointestinal malignancies. A growing number of reports focusing on oxaliplatin (OXA) resistance in CRC treatment have revealed that drug resistance is an urgent issue in clinical applica
Externí odkaz:
https://doaj.org/article/c2b67c06bca14609a120913dd07757e1